Board Change • Apr 23
High number of new directors There are 5 new directors who have joined the board in the last 3 years. Non-Executive Independent Director Sanjeev Tole was the last director to join the board, commencing their role in 2026. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model. New Risk • Apr 01
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (10% operating cash flow to total debt). Earnings have declined by 44% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.4% average weekly change). Market cap is less than US$100m (₹986.3m market cap, or US$10.6m). New Risk • Mar 13
New major risk - Market cap size The company's market capitalization is less than US$10m. Market cap: ₹883.6m (US$9.57m) This is considered a major risk. Companies with a small market capitalization are most likely businesses that have not yet released a product to market or are simply a very small company without a wide reach. Either way, risk is elevated with these companies because there is a chance the product may not come to fruition or the company's addressable market or demand may not be as large as expected. In addition, if the company's size is the main factor, it is less likely to have many investors and analysts following it and scrutinizing its performance and outlook. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (10% operating cash flow to total debt). Earnings have declined by 44% per year over the past 5 years. Market cap is less than US$10m (₹883.6m market cap, or US$9.57m). Reported Earnings • Feb 11
Third quarter 2026 earnings released: ₹10.67 loss per share (vs ₹14.13 loss in 3Q 2025) Third quarter 2026 results: ₹10.67 loss per share (improved from ₹14.13 loss in 3Q 2025). Revenue: ₹1.78b (down 5.0% from 3Q 2025). Net loss: ₹156.0m (loss narrowed 16% from 3Q 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 71 percentage points per year, which is a significant difference in performance. Reported Earnings • Nov 13
Second quarter 2026 earnings released: ₹17.02 loss per share (vs ₹21.59 loss in 2Q 2025) Second quarter 2026 results: ₹17.02 loss per share (improved from ₹21.59 loss in 2Q 2025). Revenue: ₹1.79b (down 5.1% from 2Q 2025). Net loss: ₹248.9m (loss narrowed 12% from 2Q 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 74 percentage points per year, which is a significant difference in performance. Announcement • Sep 01
Caprihans India Limited, Annual General Meeting, Sep 23, 2025 Caprihans India Limited, Annual General Meeting, Sep 23, 2025, at 12:00 Indian Standard Time. Reported Earnings • Aug 12
First quarter 2026 earnings released: ₹9.27 loss per share (vs ₹13.41 loss in 1Q 2025) First quarter 2026 results: ₹9.27 loss per share (improved from ₹13.41 loss in 1Q 2025). Revenue: ₹1.85b (up 3.7% from 1Q 2025). Net loss: ₹135.6m (loss narrowed 23% from 1Q 2025). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 81 percentage points per year, which is a significant difference in performance. Announcement • Aug 04
Caprihans India Limited to Report Q1, 2026 Results on Aug 11, 2025 Caprihans India Limited announced that they will report Q1, 2026 results on Aug 11, 2025 Reported Earnings • May 28
Full year 2025 earnings released: ₹46.26 loss per share (vs ₹39.30 loss in FY 2024) Full year 2025 results: ₹46.26 loss per share (further deteriorated from ₹39.30 loss in FY 2024). Revenue: ₹7.68b (up 10% from FY 2024). Net loss: ₹621.8m (loss widened 21% from FY 2024). Over the last 3 years on average, earnings per share has fallen by 62% per year but the company’s share price has increased by 5% per year, which means it is well ahead of earnings. New Risk • Apr 03
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.4% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (5.8% operating cash flow to total debt). Earnings have declined by 27% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (8.4% average weekly change). Market cap is less than US$100m (₹2.12b market cap, or US$24.7m). Reported Earnings • Feb 12
Third quarter 2025 earnings released: ₹14.13 loss per share (vs ₹10.39 loss in 3Q 2024) Third quarter 2025 results: ₹14.13 loss per share (further deteriorated from ₹10.39 loss in 3Q 2024). Revenue: ₹1.95b (up 21% from 3Q 2024). Net loss: ₹185.6m (loss widened 36% from 3Q 2024). Over the last 3 years on average, earnings per share has fallen by 55% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings. New Risk • Nov 22
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (5.9% operating cash flow to total debt). Earnings have declined by 14% per year over the past 5 years. Minor Risks Share price has been volatile over the past 3 months (7.6% average weekly change). Market cap is less than US$100m (₹1.87b market cap, or US$22.1m). New Risk • Nov 12
New major risk - Revenue and earnings growth Earnings have declined by 14% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (5.9% operating cash flow to total debt). Earnings have declined by 14% per year over the past 5 years. Minor Risk Market cap is less than US$100m (₹2.16b market cap, or US$25.6m). Announcement • Oct 15
Caprihans India Limited announced that it expects to receive INR 240 million in funding from Bilcare Mauritius Limited Caprihans India Limited announced a private placement of 4,800,000 for the gross proceeds of INR 50 per warrant for the gross proceeds of INR 240,000,000 on October 14, 2024. The warrants will be exercised at an exercise price of INR 150 per share. The warrants will be issued on preferential basis. The transaction will include participation from new investor, Bilcare Mauritius Limited. The transaction has been approved by the shareholders of the company. Board Change • Oct 02
High number of new and inexperienced directors There are 4 new directors who have joined the board in the last 3 years. The company's board is composed of: 4 new directors. 1 experienced director. No highly experienced directors. Chairperson, MD & President Ankita Kariya is the most experienced director on the board, commencing their role in 2018. The company’s lack of experienced directors is considered a risk according to the Simply Wall St Risk Model. Announcement • Sep 27
Caprihans India Limited Approves Appointment of Kavaseri R Viswanathan as A Non-Executive, Independent Director Caprihans India Limited approved Appointment of Mr. Kavaseri R Viswanathan as a Non-Executive, Independent Director of the Company for a term of five years effective from September 04, 2024 to September 03, 2029. Announcement • Sep 25
Caprihans India Limited Announces Cessation of Board of Directors Caprihans India Limited announced that Mr. Siddharth Shyam Shetye and Mr. Nitin Joshi, who served as an Independent Directors of the company from September 26, 2019 has concluded their tenure as an Independent Directors on the Board of the Company respectively. Their term officially ended from the close of business hours on September 25, 2024, following completion of their second term. Reason for change: Cessation of directorship due to completion of Second term as an Independent Director from the closing hours of September 25, 2024. Announcement • Sep 06
Caprihans India Limited, Annual General Meeting, Sep 26, 2024 Caprihans India Limited, Annual General Meeting, Sep 26, 2024. Reported Earnings • Aug 13
First quarter 2025 earnings released: ₹13.41 loss per share (vs ₹8.13 loss in 1Q 2024) First quarter 2025 results: ₹13.41 loss per share (further deteriorated from ₹8.13 loss in 1Q 2024). Revenue: ₹1.86b (up 10% from 1Q 2024). Net loss: ₹176.1m (loss widened 65% from 1Q 2024). Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 1% per year, which means it is well ahead of earnings. Announcement • Aug 05
Caprihans India Limited to Report Q1, 2025 Results on Aug 12, 2024 Caprihans India Limited announced that they will report Q1, 2025 results on Aug 12, 2024 Reported Earnings • May 28
Full year 2024 earnings released: ₹39.31 loss per share (vs ₹54.64 profit in FY 2023) Full year 2024 results: ₹39.31 loss per share (down from ₹54.64 profit in FY 2023). Revenue: ₹7.22b (down 22% from FY 2023). Net loss: ₹516.2m (down 172% from profit in FY 2023). Over the last 3 years on average, earnings per share has increased by 16% per year whereas the company’s share price has increased by 11% per year. New Risk • Mar 22
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 8.6% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (0.6x net interest cover). Minor Risks Share price has been volatile over the past 3 months (8.6% average weekly change). Large one-off items impacting financial results. Market cap is less than US$100m (₹2.18b market cap, or US$26.0m). Valuation Update With 7 Day Price Move • Mar 13
Investor sentiment deteriorates as stock falls 17% After last week's 17% share price decline to ₹144, the stock trades at a trailing P/E ratio of 3.1x. Average trailing P/E is 28x in the Chemicals industry in India. Total returns to shareholders of 69% over the past three years. Reported Earnings • Feb 11
Third quarter 2024 earnings released: ₹10.39 loss per share (vs ₹0.71 loss in 3Q 2023) Third quarter 2024 results: ₹10.39 loss per share (further deteriorated from ₹0.71 loss in 3Q 2023). Revenue: ₹1.67b (up 100% from 3Q 2023). Net loss: ₹136.4m (loss widened ₹127.0m from 3Q 2023). Over the last 3 years on average, earnings per share has increased by 53% per year but the company’s share price has only increased by 30% per year, which means it is significantly lagging earnings growth. New Risk • Jan 27
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Indian stocks, typically moving 7.5% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.5x net interest cover). High level of non-cash earnings (22% accrual ratio). Minor Risks Share price has been volatile over the past 3 months (7.5% average weekly change). Market cap is less than US$100m (₹2.78b market cap, or US$33.4m). Valuation Update With 7 Day Price Move • Jan 18
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to ₹235, the stock trades at a trailing P/E ratio of 5.3x. Average trailing P/E is 31x in the Chemicals industry in India. Total returns to shareholders of 173% over the past three years. Reported Earnings • Aug 12
First quarter 2024 earnings released: ₹8.13 loss per share (vs ₹1.18 profit in 1Q 2023) First quarter 2024 results: ₹8.13 loss per share (down from ₹1.18 profit in 1Q 2023). Revenue: ₹1.76b (up 60% from 1Q 2023). Net loss: ₹106.7m (down ₹122.1m from profit in 1Q 2023). Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has increased by 59% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Aug 04
Caprihans India Limited to Report Q1, 2024 Results on Aug 11, 2023 Caprihans India Limited announced that they will report Q1, 2024 results on Aug 11, 2023 New Risk • Jul 27
New major risk - Financial position The company's interest payments are not well covered by earnings. Net interest cover: 0.6x This is considered a major risk. If the company is unable to fund interest repayments on its debt through profits, it may be forced into reducing its debt burden through selling assets, undertaking a potentially costly capital raising or even into bankruptcy in the worst case scenario. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (0.6x net interest cover). Share price has been highly volatile over the past 3 months (9.1% average weekly change). Minor Risks Large one-off items impacting financial results. Market cap is less than US$100m (₹3.01b market cap, or US$36.7m). Valuation Update With 7 Day Price Move • Jul 25
Investor sentiment improves as stock rises 21% After last week's 21% share price gain to ₹227, the stock trades at a trailing P/E ratio of 26.7x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 368% over the past three years. Valuation Update With 7 Day Price Move • Jul 04
Investor sentiment improves as stock rises 15% After last week's 15% share price gain to ₹190, the stock trades at a trailing P/E ratio of 22.4x. Average trailing P/E is 22x in the Chemicals industry in India. Total returns to shareholders of 273% over the past three years. Valuation Update With 7 Day Price Move • Jun 20
Investor sentiment improves as stock rises 16% After last week's 16% share price gain to ₹164, the stock trades at a trailing P/E ratio of 19.3x. Average trailing P/E is 23x in the Chemicals industry in India. Total returns to shareholders of 222% over the past three years. Valuation Update With 7 Day Price Move • Jun 02
Investor sentiment improves as stock rises 23% After last week's 23% share price gain to ₹130, the stock trades at a trailing P/E ratio of 15.2x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 225% over the past three years. Announcement • May 19
Caprihans India Limited to Report Fiscal Year 2023 Results on May 26, 2023 Caprihans India Limited announced that they will report fiscal year 2023 results on May 26, 2023 Valuation Update With 7 Day Price Move • Mar 08
Investor sentiment improves as stock rises 17% After last week's 17% share price gain to ₹121, the stock trades at a trailing P/E ratio of 14.2x. Average trailing P/E is 20x in the Chemicals industry in India. Total returns to shareholders of 254% over the past three years. Reported Earnings • Feb 08
Third quarter 2023 earnings released: ₹0.71 loss per share (vs ₹3.84 profit in 3Q 2022) Third quarter 2023 results: ₹0.71 loss per share (down from ₹3.84 profit in 3Q 2022). Revenue: ₹854.0m (down 14% from 3Q 2022). Net loss: ₹9.35m (down 119% from profit in 3Q 2022). Over the last 3 years on average, earnings per share has increased by 14% per year but the company’s share price has increased by 35% per year, which means it is tracking significantly ahead of earnings growth. Announcement • Feb 02
Caprihans India Limited to Report Q3, 2023 Results on Feb 07, 2023 Caprihans India Limited announced that they will report Q3, 2023 results at 12:15 PM, Indian Standard Time on Feb 07, 2023 Announcement • Dec 29
Caprihans India Limited Approves Executive Changes The board of directors of Caprihans India Limited at meeting held on December 28, 2022, approved the appointment of Mr. Sudhir Pendse as Non-Executive Independent Director (Additional Director) of the company to hold such office with effect from December 28, 2022 upto the date of the upcoming Annual/Extra Ordinary General Meeting of the Company. Mr. Pendse is a Commerce Graduate with Diploma in Exim Policies and Procedure . He also holds diploma in French language He has more than 30 years of experience in the field of Export Import, Exim logistics etc.; The company approved the resignation of Mr. Narendra Kumar Lodha as Non- Executive Non Independent Director with effect immediate effect., resignation of Mr. Chandrashekhar Joglekar as Non- Executive Non Independent Director of the Company with immediate effect.; resignation of Mr. Tanuj Kumar Lodha as Non- Executive Independent Director of the Company with immediate effect due to prior engagement and continuous travel. Valuation Update With 7 Day Price Move • Dec 28
Investor sentiment improved over the past week After last week's 17% share price gain to ₹138, the stock trades at a trailing P/E ratio of 10.6x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 212% over the past three years. Reported Earnings • Nov 10
Second quarter 2023 earnings released: EPS: ₹4.35 (vs ₹1.43 in 2Q 2022) Second quarter 2023 results: EPS: ₹4.35 (up from ₹1.43 in 2Q 2022). Revenue: ₹935.8m (flat on 2Q 2022). Net income: ₹57.2m (up 204% from 2Q 2022). Profit margin: 6.1% (up from 2.0% in 2Q 2022). Over the last 3 years on average, earnings per share has increased by 28% per year but the company’s share price has increased by 49% per year, which means it is tracking significantly ahead of earnings growth. Valuation Update With 7 Day Price Move • Nov 07
Investor sentiment improved over the past week After last week's 23% share price gain to ₹163, the stock trades at a trailing P/E ratio of 16.1x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 263% over the past three years. Announcement • Oct 30
Caprihans India Limited to Report Q2, 2023 Results on Nov 05, 2022 Caprihans India Limited announced that they will report Q2, 2023 results at 12:15 PM, Indian Standard Time on Nov 05, 2022 Announcement • Oct 20
Caprihans India Limited Announces Change in Directorate Caprihans India Limited announced Resignation of Mr. Robin Banerjee, Managing Director: Mr. Robin Banerjee has resigned from position of the Managing Director of the Company vide his letter dated October 18, 2022 with effect from October 19, 2022. Mr. Shreyans Mohan Bhandari is appointed as Non-Executive Non-Independent Director of the Company to hold such office with effect from October 19, 2022 upto the date of the ensuing Annual/Extra Ordinary General Meeting of the Company. Board Change • Oct 02
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 3 experienced directors. 4 highly experienced directors. Additional Non- Executive Independent Director Tanuj Lodha was the last director to join the board, commencing their role in 2022. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Announcement • Aug 11
Caprihans India Limited Appoints Tanuj Lodha as A Non- Executive Independent Caprihans India Limited appointed Tanuj Lodha as a Non- Executive Independent for period of 5 years with effect from May 03, 2022 upto May 02, 2027 at its AGM held on August 10, 2022. Mr. Tanuj Lodha aged 42, is an Advocate by profession and is a Senior Partner at Lodha & Lodha Advocates. Mr. Lodha is a Bachelor of Law (LLB), Chartered Accountant, MBA finance & marketing from the Indian School of Business. Mr. Lodha specializes in commercial laws including Arbitration, IBC, Real Estate & Company Laws. Mr. Lodha has represented several Corporates and other Persons in important matters and has appeared in several reported judgements' 'Mr. Lodha is an avid Golfer and actively participates in charitable causes. Announcement • Jul 28
Caprihans India Limited to Report Q1, 2023 Results on Aug 05, 2022 Caprihans India Limited announced that they will report Q1, 2023 results on Aug 05, 2022 Reported Earnings • Jul 20
Full year 2022 earnings released: EPS: ₹12.79 (vs ₹15.40 in FY 2021) Full year 2022 results: EPS: ₹12.79 (down from ₹15.40 in FY 2021). Revenue: ₹3.93b (up 33% from FY 2021). Net income: ₹167.9m (down 17% from FY 2021). Profit margin: 4.3% (down from 6.8% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 51% per year whereas the company’s share price has increased by 56% per year. Announcement • Jul 19
Caprihans India Limited, Annual General Meeting, Aug 10, 2022 Caprihans India Limited, Annual General Meeting, Aug 10, 2022, at 11:00 Indian Standard Time. Agenda: To receive, consider and adopt the Audited Standalone Financial Statements of the Company for the Financial Year ended March 31, 2022; to appoint a Director in place of Mr. Chandrashekhar Joglekar (DIN: 07265143); to appoint Mr. Tanuj Kumar Lodha (DIN: 06874388) as a Non-Executive, Independent Director of the Company; to ratify remuneration of Cost Auditors; and to reappoint Mr. Robin Banerjee (DIN 00008893) as Managing Director and payment of remuneration. Valuation Update With 7 Day Price Move • Jun 08
Investor sentiment improved over the past week After last week's 16% share price gain to ₹132, the stock trades at a trailing P/E ratio of 10.3x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 148% over the past three years. Reported Earnings • May 15
Full year 2022 earnings released: EPS: ₹12.79 (vs ₹15.40 in FY 2021) Full year 2022 results: EPS: ₹12.79 (down from ₹15.40 in FY 2021). Revenue: ₹3.97b (up 35% from FY 2021). Net income: ₹167.9m (down 17% from FY 2021). Profit margin: 4.2% (down from 6.8% in FY 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 51% per year but the company’s share price has only increased by 25% per year, which means it is significantly lagging earnings growth. Announcement • May 07
Caprihans India Limited to Report Fiscal Year 2022 Results on May 12, 2022 Caprihans India Limited announced that they will report fiscal year 2022 results on May 12, 2022 Board Change • Apr 27
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 5 experienced directors. 1 highly experienced director. Non-Executive & Non-Independent Director Chandrashekhar Joglekar was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Apr 01
Investor sentiment improved over the past week After last week's 17% share price gain to ₹136, the stock trades at a trailing P/E ratio of 9.2x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 132% over the past three years. Announcement • Mar 30
Caprihans India Limited Announces Resignation of Anjali Seth as Independent Director Caprihans India Limited announced that Ms. Anjali Seth (DIN: 05234352), Independent Director, vide letter dated March 29, 2022, has tendered her resignation from the Board of the Company. Reported Earnings • Feb 11
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Third quarter 2022 results: EPS: ₹3.84 (down from ₹4.31 in 3Q 2021). Revenue: ₹1.00b (up 38% from 3Q 2021). Net income: ₹50.4m (down 11% from 3Q 2021). Profit margin: 5.0% (down from 7.8% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue was in line with analyst estimates. Over the last 3 years on average, earnings per share has increased by 60% per year but the company’s share price has only increased by 31% per year, which means it is significantly lagging earnings growth. Announcement • Feb 03
Caprihans India Limited to Report Q3, 2022 Results on Feb 10, 2022 Caprihans India Limited announced that they will report Q3, 2022 results on Feb 10, 2022 Board Change • Jan 02
Insufficient new directors There is 1 new director who has joined the board in the last 3 years. The company's board is composed of: 1 new director. 6 experienced directors. 1 highly experienced director. Non-Executive & Non-Independent Director Chandrashekhar Joglekar was the last director to join the board, commencing their role in 2019. The company’s insufficient board refreshment is considered a risk according to the Simply Wall St Risk Model. Valuation Update With 7 Day Price Move • Dec 28
Investor sentiment improved over the past week After last week's 17% share price gain to ₹138, the stock trades at a trailing P/E ratio of 9.1x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 102% over the past three years. Reported Earnings • Nov 11
Second quarter 2022 earnings released: EPS ₹1.43 (vs ₹3.71 in 2Q 2021) The company reported a soft second quarter result with weaker earnings and profit margins, although revenues improved. Second quarter 2022 results: Revenue: ₹943.3m (up 23% from 2Q 2021). Net income: ₹18.8m (down 61% from 2Q 2021). Profit margin: 2.0% (down from 6.3% in 2Q 2021). The decrease in margin was driven by higher expenses. Over the last 3 years on average, earnings per share has increased by 65% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Aug 30
Investor sentiment improved over the past week After last week's 18% share price gain to ₹151, the stock trades at a trailing P/E ratio of 8.7x. Average trailing P/E is 17x in the Chemicals industry in India. Total returns to shareholders of 95% over the past three years. Reported Earnings • Aug 09
First quarter 2022 earnings released: EPS ₹3.83 (vs ₹1.77 in 1Q 2021) The company reported a strong first quarter result with improved earnings, revenues and profit margins. First quarter 2022 results: Revenue: ₹851.6m (up 49% from 1Q 2021). Net income: ₹50.3m (up 117% from 1Q 2021). Profit margin: 5.9% (up from 4.1% in 1Q 2021). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 66% per year but the company’s share price has only increased by 28% per year, which means it is significantly lagging earnings growth. Reported Earnings • Jun 27
Full year 2021 earnings released: EPS ₹15.40 (vs ₹7.00 in FY 2020) The company reported a strong full year result with improved earnings, revenues and profit margins. Full year 2021 results: Revenue: ₹3.04b (up 5.6% from FY 2020). Net income: ₹202.2m (up 120% from FY 2020). Profit margin: 6.6% (up from 3.2% in FY 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has only increased by 31% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Jun 09
Investor sentiment improved over the past week After last week's 16% share price gain to ₹132, the stock trades at a trailing P/E ratio of 9.9x. Average trailing P/E is 21x in the Chemicals industry in India. Total returns to shareholders of 69% over the past three years. Valuation Update With 7 Day Price Move • May 11
Investor sentiment improved over the past week After last week's 37% share price gain to ₹130, the stock trades at a trailing P/E ratio of 9.8x. Average trailing P/E is 19x in the Chemicals industry in India. Total returns to shareholders of 56% over the past three years. Valuation Update With 7 Day Price Move • Apr 27
Investor sentiment improved over the past week After last week's 19% share price gain to ₹93.00, the stock trades at a trailing P/E ratio of 7x. Average trailing P/E is 18x in the Chemicals industry in India. Total returns to shareholders of 8.1% over the past three years. Announcement • Feb 04
Caprihans India Limited to Report Q3, 2021 Results on Feb 10, 2021 Caprihans India Limited announced that they will report Q3, 2021 results on Feb 10, 2021 Announcement • Jan 22
Caprihans India Limited Announces Sad Demise of K.V. Mani, Independent Director of the Company Caprihans India Limited announced the sad demise of Mr. K.V. Mani (DIN: 00533148), Independent Director of the Company on the night of January 20, 2021. Valuation Update With 7 Day Price Move • Dec 29
Investor sentiment improved over the past week After last week's 20% share price gain to ₹87.30, the stock is trading at a trailing P/E ratio of 8.4x, up from the previous P/E ratio of 7x. This compares to an average P/E of 18x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 23%. Is New 90 Day High Low • Dec 28
New 90-day high: ₹84.40 The company is up 56% from its price of ₹54.15 on 29 September 2020. The Indian market is up 20% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 19% over the same period. Is New 90 Day High Low • Dec 08
New 90-day high: ₹81.15 The company is up 51% from its price of ₹53.75 on 09 September 2020. The Indian market is up 18% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 18% over the same period. Valuation Update With 7 Day Price Move • Nov 23
Market bids up stock over the past week After last week's 16% share price gain to ₹76.15, the stock is trading at a trailing P/E ratio of 7.3x, up from the previous P/E ratio of 6.3x. This compares to an average P/E of 16x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 32%. Valuation Update With 7 Day Price Move • Nov 17
Market bids up stock over the past week After last week's 18% share price gain to ₹75.45, the stock is trading at a trailing P/E ratio of 7.3x, up from the previous P/E ratio of 6.2x. This compares to an average P/E of 16x in the Chemicals industry in India. Total return to shareholders over the past three years is a loss of 32%. Reported Earnings • Nov 11
Second quarter 2021 earnings released: EPS ₹3.71 The company reported a strong second quarter result with improved earnings, revenues and profit margins. Second quarter 2021 results: Revenue: ₹819.3m (up 5.8% from 2Q 2020). Net income: ₹48.7m (up 205% from 2Q 2020). Profit margin: 5.9% (up from 2.1% in 2Q 2020). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 37% per year but the company’s share price has fallen by 16% per year, which means it is significantly lagging earnings. Is New 90 Day High Low • Nov 09
New 90-day high: ₹66.80 The company is up 27% from its price of ₹52.50 on 11 August 2020. The Indian market is up 7.0% over the last 90 days, indicating the company outperformed over that time. It also outperformed the Chemicals industry, which is up 11% over the same period. Announcement • Aug 09
Caprihans India Limited to Report Q1, 2021 Results on Aug 12, 2020 Caprihans India Limited announced that they will report Q1, 2021 results on Aug 12, 2020 Announcement • Jun 17
Caprihans India Limited to Report Fiscal Year 2020 Results on Jun 19, 2020 Caprihans India Limited announced that they will report fiscal year 2020 results on Jun 19, 2020